Schroder Investment Management Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.8M | Sell |
8,580
-19,203
| -69% | -$6.26M | ﹤0.01% | 862 |
|
2025
Q1 | $7.46M | Buy |
27,783
+4,553
| +20% | +$1.22M | 0.01% | 686 |
|
2024
Q4 | $5.48M | Sell |
23,230
-24,112
| -51% | -$5.69M | 0.01% | 758 |
|
2024
Q3 | $13M | Sell |
47,342
-9,382
| -17% | -$2.58M | 0.01% | 614 |
|
2024
Q2 | $13.8M | Sell |
56,724
-32,178
| -36% | -$7.82M | 0.02% | 567 |
|
2024
Q1 | $13.3M | Buy |
88,902
+44,427
| +100% | +$6.64M | 0.02% | 592 |
|
2023
Q4 | $8.51M | Buy |
44,475
+36,820
| +481% | +$7.05M | 0.01% | 665 |
|
2023
Q3 | $1.36M | Sell |
7,655
-548
| -7% | -$97.1K | ﹤0.01% | 970 |
|
2023
Q2 | $1.56M | Sell |
8,203
-661
| -7% | -$126K | ﹤0.01% | 980 |
|
2023
Q1 | $1.78M | Buy |
8,864
+384
| +5% | +$76.9K | ﹤0.01% | 971 |
|
2022
Q4 | $2.02M | Sell |
8,480
-598
| -7% | -$142K | ﹤0.01% | 940 |
|
2022
Q3 | $1.82M | Sell |
9,078
-1,745
| -16% | -$349K | ﹤0.01% | 958 |
|
2022
Q2 | $1.58M | Buy |
10,823
+891
| +9% | +$130K | ﹤0.01% | 1009 |
|
2022
Q1 | $1.64M | Buy |
9,932
+4,221
| +74% | +$697K | ﹤0.01% | 1043 |
|
2021
Q4 | $968K | Buy |
5,711
+758
| +15% | +$128K | ﹤0.01% | 1039 |
|
2021
Q3 | $935K | Buy |
4,953
+297
| +6% | +$56.1K | ﹤0.01% | 1113 |
|
2021
Q2 | $789K | Buy |
4,656
+911
| +24% | +$154K | ﹤0.01% | 1174 |
|
2021
Q1 | $529K | Hold |
3,745
| – | – | ﹤0.01% | 1252 |
|
2020
Q4 | $487K | Hold |
3,745
| – | – | ﹤0.01% | 1202 |
|
2020
Q3 | $508K | Buy |
3,745
+206
| +6% | +$27.9K | ﹤0.01% | 1091 |
|
2020
Q2 | $524K | Buy |
3,539
+1,534
| +77% | +$227K | ﹤0.01% | 999 |
|
2020
Q1 | $225K | Buy |
+2,005
| New | +$225K | ﹤0.01% | 1086 |
|
2018
Q1 | – | Sell |
-3,216
| Closed | -$409K | – | 1270 |
|
2017
Q4 | $409K | Buy |
+3,216
| New | +$409K | ﹤0.01% | 1124 |
|
2017
Q3 | – | Sell |
-22,913
| Closed | -$1.81M | – | 1320 |
|
2017
Q2 | $1.81M | Hold |
22,913
| – | – | ﹤0.01% | 881 |
|
2017
Q1 | $1.17M | Buy |
22,913
+9,793
| +75% | +$502K | ﹤0.01% | 930 |
|
2016
Q4 | $491K | Sell |
13,120
-5,472
| -29% | -$205K | ﹤0.01% | 972 |
|
2016
Q3 | $1.26M | Hold |
18,592
| – | – | ﹤0.01% | 886 |
|
2016
Q2 | $1.03M | Buy |
18,592
+13,042
| +235% | +$724K | ﹤0.01% | 906 |
|
2016
Q1 | $328K | Hold |
5,550
| – | – | ﹤0.01% | 1002 |
|
2015
Q4 | $522K | Hold |
5,550
| – | – | ﹤0.01% | 974 |
|
2015
Q3 | $446K | Hold |
5,550
| – | – | ﹤0.01% | 971 |
|
2015
Q2 | $634K | Sell |
5,550
-6,864
| -55% | -$784K | ﹤0.01% | 958 |
|
2015
Q1 | $1.29M | Hold |
12,414
| – | – | ﹤0.01% | 904 |
|
2014
Q4 | $1.2M | Sell |
12,414
-10,768
| -46% | -$1.04M | ﹤0.01% | 974 |
|
2014
Q3 | $1.81M | Buy |
23,182
+374
| +2% | +$29.2K | ﹤0.01% | 921 |
|
2014
Q2 | $1.44M | Buy |
22,808
+6,696
| +42% | +$423K | ﹤0.01% | 917 |
|
2014
Q1 | $1.08M | Sell |
16,112
-5,695
| -26% | -$382K | ﹤0.01% | 961 |
|
2013
Q4 | $1.4M | Sell |
21,807
-3,863
| -15% | -$248K | ﹤0.01% | 990 |
|
2013
Q3 | $1.64M | Sell |
25,670
-5,225
| -17% | -$334K | ﹤0.01% | 950 |
|
2013
Q2 | $958K | Buy |
+30,895
| New | +$958K | ﹤0.01% | 1011 |
|